On this page of StockholderLetter.com we present the latest annual shareholder letter from MYRIAD GENETICS INC — ticker symbol MYGN. Reading current and past MYGN letters to shareholders can bring important insights into the investment thesis.
MYRIAD GENETICS INC shareholder letter page 1
MYRIAD GENETICS INC shareholder letter page 2
 • Continue to Full 4/17/2024 Report
 • stockholder letter icon More "Biotechnology" Category Stockholder Letters
 • Benford's Law Stocks icon MYGN Benford's Law Stock Score = 73


MYGN Shareholder/Stockholder Letter Transcript:

MYRIAD GENETICS INC shareholder letter page 1MYRIAD GENETICS INC shareholder letter page 2

Continue to Full 4/17/2024 Report
 

MYGN Stockholder/Shareholder Letter (MYRIAD GENETICS INC) | www.StockholderLetter.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.